Pro Dex (PDEX) Net Margin (2010 - 2026)

Pro Dex (PDEX) posted Net Margin of 19.74% for Q1 2026, up 68.46% sequentially from 11.72% in Q4 2025, and up 93.0% YoY from 10.23% in Q1 2025.

Pro Dex (PDEX) Net Margin (2010 - 2026) Analysis & Trends

Pro Dex has reported Net Margin for 14 years, with the latest figure at 19.74% in Q1 2026.

Quarterly Net Margin rose 93.0% year-over-year to 19.74% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.08% (up 147.0% YoY) and the FY2025 annual result came in at 13.48%, up 953.0% from the prior year.
Net Margin climbed to 19.74% in Q1 2026 per PDEX's latest filing, from 11.72% in the prior quarter.
Over five years, Net Margin peaked at 25.26% in Q3 2025 and troughed at 5.15% in Q3 2023.
A 5-year average of 12.79% and a median of 12.15% in 2024 frame the typical range for Net Margin.
The sharpest annual moves came in 2023 and 2024: Net Margin plunged 2042 bps in 2023, then soared 2171 bps in 2024.
Over 5 years, Net Margin stood at 24.39% in 2022, then slumped by 84 bps to 3.97% in 2023, then surged by 206 bps to 12.15% in 2024, then declined by 4 bps to 11.72% in 2025, then soared by 68 bps to 19.74% in 2026.
According to Business Quant data, Net Margin over the past three periods registered 19.74%, 11.72%, and 25.26% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	28.46%
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	7.59%
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	-
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	26.20%
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	1.81%
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	16.96%
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	4.21%
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	-7.20%
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	4.26%
10	Pro Dex	215.72 Mn	204.74 Mn	6.13 Mn	19.74%

Download Data